Bridges Investment Counsel’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$823K Sell
5,032
-490
-9% -$87.9K 0.45% 61
2017
Q3
$1.13M Sell
5,522
-16,386
-75% -$3.81M 0.63% 49
2017
Q2
$5.33M Buy
21,908
+11,086
+102% +$2.61M 1.21% 29
2017
Q1
$2.59M Sell
10,822
-11,305
-51% -$2.63M 0.76% 31
2016
Q4
$4.65M Sell
22,127
-1,407
-6% -$291K 1.13% 33
2016
Q3
$5.42M Buy
23,534
+95
+0.4% +$23.2K 1.14% 26
2016
Q2
$5.42M Buy
23,439
+375
+2% +$86.5K 1.19% 22
2016
Q1
$6.18M Sell
23,064
-9,223
-29% -$2.64M 1.33% 21
2015
Q4
$9.8M Hold
32,287
1.7% 16
2015
Q3
$9.8M Buy
32,287
+8,378
+35% +$2.57M 1.7% 16
2015
Q2
$7.26M Buy
23,909
+65
+0.3% +$19.4K 1.71% 15
2015
Q1
$7.1M Buy
23,844
+304
+1% +$86.7K 1.62% 15
2014
Q4
$6.06M Sell
23,540
-200
-0.8% -$50K 1.39% 24
2014
Q3
$5.73M Sell
23,740
-45
-0.2% -$10.1K 1.32% 23
2014
Q2
$5.31M Sell
23,785
-1,115
-4% -$231K 1.22% 27
2014
Q1
$5.13M Hold
24,900
1.19% 26
2013
Q4
$4.18M Buy
24,900
+360
+1% +$56.3K 0.96% 34
2013
Q3
$3.53M Sell
24,540
-675
-3% -$89.9K 0.88% 38
2013
Q2
$3.18M Buy
+25,215
New +$2.85M 0.82% 42

Other funds holding AGN

Bridges Investment Counsel's AGN Position: Q4 2017 in Review

Bridges Investment Counsel reduced its Allergan plc (AGN) stake by 8.9% in Q4 2017, selling an estimated $87.9K and leaving 5,032 shares worth $823K. The position accounts for 0.45% of the portfolio, ranked #61.

Bridges Investment Counsel first reported a position in AGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $9.8M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Bridges Investment Counsel held 5,032 shares of Allergan plc worth $823K as of Q4 2017.
  • Bridges Investment Counsel sold 490 Allergan plc shares in Q4 2017, an estimated $87.9K.
  • Allergan plc made up 0.45% of Bridges Investment Counsel's portfolio in Q4 2017, its #61 holding.
  • Bridges Investment Counsel first reported a position in Allergan plc in Q2 2013 and has held it in 19 quarters since.
  • Bridges Investment Counsel's Allergan plc position peaked at $9.8M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.